1. External validation of a model to determine risk of progression of Barrett’s oesophagus to neoplasia
- Author
-
Richard C. Turkington, Aaron P. Thrift, Damian T. McManus, Helen G. Coleman, Andrew T. Kunzmann, Anna Gavin, and Brian T. Johnston
- Subjects
Male ,Risk ,medicine.medical_specialty ,Esophageal Neoplasms ,Esophageal Neoplasms/epidemiology ,Adenocarcinoma/epidemiology ,Population ,Adenocarcinoma ,Gastroenterology ,Barrett Esophagus ,03 medical and health sciences ,0302 clinical medicine ,Metaplasia ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,education ,Proportional Hazards Models ,Retrospective Studies ,Barrett Esophagus/complications ,education.field_of_study ,Hepatology ,Receiver operating characteristic ,business.industry ,Proportional hazards model ,External validation ,Intestinal metaplasia ,Retrospective cohort study ,Middle Aged ,medicine.disease ,digestive system diseases ,Intestines ,Dysplasia ,Disease Progression ,Female ,030211 gastroenterology & hepatology ,Intestines/pathology ,medicine.symptom ,business - Abstract
Background: A risk prediction model containing sex, smoking history, Barrett’s oesophagus length and presence of low-grade dysplasia was found to identify individuals at a higher risk of progression to oesophageal adenocarcinoma or high-grade dysplasia. Aims: To externally validate the model predicting risk of progression from Barrett’s oesophagus to neoplasia and assess the predictive utility of additional factors. Methods: We conducted a retrospective cohort study among individuals from the population-based Northern Ireland Barrett’s register with a histologically confirmed diagnosis of Barrett’s oesophagus (with intestinal metaplasia) between 1993 and 2005. The association between a points based model and risk of progression to high-grade dysplasia or oesophageal adenocarcinoma until 2010 was assessed using Cox Proportional Hazards model. Model performance was assessed using area under the receiver operating characteristics curves (AUROC), sensitivity and specificity.Results: We identified 1,198 individuals with Barrett’s oesophagus of whom 54 progressed. The model discriminated reasonably well between progressors and non-progressors, with an AUROC of 0.70 (95% CI 0.63-0.78). When categorised into low, intermediate and high risk groups, the AUROC was 0.68 (95% CI 0.61-0.74). Compared to using data on dysplasia and segment length for risk stratification, the model resulted in a net reclassification improvement of 20.9%.Conclusions: This external validation provides further evidence that a model based on sex, smoking, Barrett’s segment length and baseline low-grade dysplasia may help to risk stratify patients after an initial diagnosis of Barrett’s oesophagus. The model also performed better than the use of low-grade dysplasia status alone for risk-stratification.
- Published
- 2019